Medicare Enrolled
Dr. Chaitanya Mahida, M.D.
Internal Medicine · Oakdale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mahida from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahida?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mahida
Dr. Chaitanya Mahida is an internal medicine specialist in Oakdale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mahida performed 5,449 Medicare services across 2,848 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mahida received a total of $3,269 from 21 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mahida is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$3,269 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,449
Medicare services
Top 5% in CA for internal medicine
2,848
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~287 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,440 | $18 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,135 | $62 | $105 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
364 | $134 | $150 |
| Annual alcohol misuse screening, 5 to 15 minutes | 350 | $20 | $25 |
| Annual depression screening | 349 | $20 | $25 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
328 | $83 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
291 | $91 | $150 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
261 | $50 | $80 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
158 | $18 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
114 | $30 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
111 | $72 | $75 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
93 | $2 | $10 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
86 | $10 | $50 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
72 | $106 | $150 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
50 | $66 | $86 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
35 | $231 | $325 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $132 | $205 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $10 | $30 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
28 | $172 | $193 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
23 | $7 | $21 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
21 | $171 | $245 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
19 | $4 | $25 |
| New patient office visit, complex (60-74 min) | 17 | $155 | $250 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
15 | $49 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $85 | $180 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
13 | $15 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,269
Total received (2018-2024)
Avg $545/year across 6 years
Top 20% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,269 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$105
2023
$14
2022
$15
2020
$296
2019
$1,347
2018
$1,492
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$49
PFIZER INC.
$21
Novo Nordisk Inc
$18
AstraZeneca Pharmaceuticals LP
$17
Top 3 companies account for 83.4% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$468
Boehringer Ingelheim Pharmaceuticals, Inc.
$435
Amgen Inc.
$385
Novo Nordisk Inc
$356
AstraZeneca Pharmaceuticals LP
$350
GlaxoSmithKline, LLC.
$337
Astellas Pharma US Inc
$190
Novartis Pharmaceuticals Corporation
$149
Janssen Pharmaceuticals, Inc
$134
SANOFI-AVENTIS U.S. LLC
$99
Teva Pharmaceuticals USA, Inc.
$81
Lilly USA, LLC
$64
E.R. Squibb & Sons, L.L.C.
$59
Horizon Pharma plc
$34
Merck Sharp & Dohme Corporation
$26
Boston Scientific Corporation
$25
Allergan, Inc.
$23
ABBVIE INC.
$15
Philips Electronics North America Corporation
$13
Purdue Pharma L.P.
$13
Horizon Therapeutics plc
$13
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AJOVY · ANORO · Aimovig · BREO · BREZTRI · CHANTIX · DUEXIS · ELIQUIS · ENTRESTO · EUCRISA · EVENITY · FARXIGA · GENERAL - PAIN MANAGEMENT · ILARIS · JANUVIA · JARDIANCE · LYRICA · MYRBETRIQ · Ozempic · PRALUENT · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QVAR · SHINGRIX · SIVEXTRO · SOLIQUA · SPIRIVA · SPIRIVA RESPIMAT · SYMBICORT · SYMPROIC · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · Victoza · XARELTO · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
224
Per 100K population
40.6
County median income
$79,661
Nearest hospital
OAK VALLEY HOSPITAL DISTRICT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mahida is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mahida experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Mahida performed 1,440 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahida receive payments from pharmaceutical companies?
Yes. Dr. Mahida received a total of $3,269 from 21 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahida's costs compare to other internal medicine physicians in Oakdale?
Dr. Mahida's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahida) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Oakdale
Browse internal medicine physicians in Oakdale ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology